scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00259-018-4113-1 |
P698 | PubMed publication ID | 30155553 |
P50 | author | Susanna Schraen | Q57699004 |
Xavier Delbeuck | Q58876092 | ||
Alice Jaillard | Q91191511 | ||
Florence Pasquier | Q32424751 | ||
P2093 | author name string | Adeline Rollin-Sillaire | |
Stéphanie Bombois | |||
Franck Semah | |||
Aurélien Maureille | |||
Matthieu Vanhoutte | |||
Emilie Skrobala | |||
P2860 | cites work | 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease | Q47960333 |
Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans | Q48095120 | ||
Frontotemporal behavioral scale. | Q48314366 | ||
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study | Q48346607 | ||
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study | Q48381623 | ||
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study | Q48387371 | ||
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease | Q48536651 | ||
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers | Q50108175 | ||
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. | Q50764182 | ||
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease. | Q50913605 | ||
Mattis dementia rating scale: Internal reliability study using a diffusely impaired population | Q52100627 | ||
A new clinical scale for the staging of dementia. | Q52220854 | ||
Longitudinal stability of CSF biomarkers in Alzheimer's disease. | Q53286684 | ||
CSF biomarkers predict a more malignant outcome in Alzheimer disease. | Q53309901 | ||
Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
Cortical Surface-Based Analysis | Q28124697 | ||
Executive function and the frontal lobes: a meta-analytic review | Q28248011 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
High-resolution intersubject averaging and a coordinate system for the cortical surface | Q29615081 | ||
Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data | Q31063278 | ||
A disease-specific metabolic brain network associated with corticobasal degeneration | Q34399253 | ||
Correction for partial volume effects in PET: principle and validation | Q34468480 | ||
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease | Q34526181 | ||
Neuropathology of variants of progressive supranuclear palsy | Q34621283 | ||
Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery | Q34848342 | ||
Visual association test to detect early dementia of the Alzheimer type | Q35468591 | ||
Nonamnestic presentations of early-onset Alzheimer's disease | Q36763709 | ||
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease | Q36912674 | ||
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. | Q37220632 | ||
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. | Q37283742 | ||
Accurate and robust brain image alignment using boundary-based registration | Q37322859 | ||
Relationships between biomarkers in aging and dementia | Q37393992 | ||
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study | Q40349700 | ||
Staging of Alzheimer's disease-related neurofibrillary changes | Q40416705 | ||
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease | Q42470207 | ||
Teaching NeuroImages: FDG-PET in progressive supranuclear palsy | Q43109162 | ||
The meaning of cognitive impairment in the elderly | Q44556333 | ||
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction | Q44762713 | ||
Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease. | Q46013705 | ||
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease | Q46078133 | ||
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease | Q46121140 | ||
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients | Q46486075 | ||
An empirical comparison of surface-based and volume-based group studies in neuroimaging | Q47578645 | ||
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study. | Q47589923 | ||
Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease | Q47747859 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
early-onset Alzheimer's disease | Q5326566 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 324-333 | |
P577 | publication date | 2018-08-28 | |
P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
P1476 | title | The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease | |
P478 | volume | 46 |
Search more.